Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis

Abbate, 2013, Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction from the Virginia commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study, Am. J. Cardiol., 111, 1394, 10.1016/j.amjcard.2013.01.287 Abe, 2012, Influence of severe sarcopenia on cardiovascular risk factors in nonobese men, Metab. Syndr. Relat. Disord., 10, 407, 10.1089/met.2012.0057 Aday, 2019, Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease, Front. Cardiovasc. Med., 6, 16, 10.3389/fcvm.2019.00016 Acosta, 2013, A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nat. Cell Biol., 15, 978, 10.1038/ncb2784 Aggarwal, 2014, Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease, Inflamm. Bowel Dis., 20, 1593, 10.1097/MIB.0000000000000109 Ahmadmehrabi, 2017, Gut microbiome and its role in cardiovascular diseases, Curr. Opin. Cardiol., 32, 761, 10.1097/HCO.0000000000000445 Alexopoulos, 2013, Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (beyond endorsed Lipid lowering with EBT Scanning), J. Am. Coll. Cardiol., 61, 1956, 10.1016/j.jacc.2012.12.051 Alí, 2019, Cardiolipotoxicity, inflammation, and arrhythmias: role for Interleukin-6 molecular mechanisms, Front. Physiol., 9, 1866, 10.3389/fphys.2018.01866 Ali, 2018, Regulation of mitochondrial dynamics by proteolytic processing and protein turnover, Antioxidants (Basel, 7 Amor, 2019, Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans, Exp. Clin. Endocrinol. Diabetes, 127, 550, 10.1055/a-0641-5546 Ansaldo, 2019, Epicardial adipose tissue and cardiovascular diseases, Int. J. Cardiol., 278, 254, 10.1016/j.ijcard.2018.09.089 Antonopoulos, 2017, The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles, J. Physiol., 595, 3907, 10.1113/JP273049 Antonopoulos, 2016, Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-γ/adiponectin signalling, Circ. Res., 118, 842, 10.1161/CIRCRESAHA.115.307856 Apostolopoulos, 2016, The complex immunological and inflammatory network of adipose tissue in obesity, Mol. Nutr. Food Res., 60, 43, 10.1002/mnfr.201500272 Aquila, 2019, The use of nutraceuticals to counteract atherosclerosis: the role of the notch pathway, Oxid. Med. Cell. Longevity, 2019, 10.1155/2019/5470470 Araújo, 2017, Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity, Biochimie, 141, 97, 10.1016/j.biochi.2017.05.019 Arutyunov, 2008, Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure, Int. J. Cardiol., 125, 240, 10.1016/j.ijcard.2007.11.103 Aulin, 2015, Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation, Am. Heart J., 170, 1151, 10.1016/j.ahj.2015.09.018 Avolio, 2019, Obesity and body composition in man and woman: associated diseases and new role of gut microbiota, Curr. Med. Chem., 10.2174/0929867326666190326113607 Baar, 2018, Musculoskeletal senescence: a moving target ready to be eliminated, Curr. Opin. Pharmacol., 40, 147, 10.1016/j.coph.2018.05.007 Bach Knudsen, 2018, Impact of diet-modulated butyrate production on intestinal barrier function and inflammation, Nutrients, 10, E1499, 10.3390/nu10101499 Bäck, 2019, Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities, Nat. Rev. Cardiol., 16, 389, 10.1038/s41569-019-0169-2 Bäckhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. U. S. A., 101, 15718, 10.1073/pnas.0407076101 Bäckhed, 2007, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc. Natl. Acad. Sci. U. S. A., 104, 979, 10.1073/pnas.0605374104 Baker, 2016, Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan, Nature, 530, 184, 10.1038/nature16932 Baker, 2008, Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency, Nat. Cell Biol., 10, 825, 10.1038/ncb1744 Baker, 2018, Resolvin E1 (Rv E1) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes, J. Cell. Biochem., 119, 6094, 10.1002/jcb.26807 Bandet, 2019, Sphingolipid metabolism: new insight into ceramide-induced lipotoxicity in muscle cells, Int. J. Mol. Sci., 20, E479, 10.3390/ijms20030479 Barazzoni, 2018, Sarcopenic obesity: time to meet the challenge, Obes. Facts, 11, 294, 10.1159/000490361 Barrea, 2019, From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?, Hormones (Athens), 10.1007/s42000-019-00100-0 Barth, 2004, X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update, Am. J. Med. Genet. A, 126A, 349, 10.1002/ajmg.a.20660 Basil, 2016, Specialized pro-resolving mediators: endogenous regulators of infection and inflammation, Nat. Rev. Immunol., 16, 51, 10.1038/nri.2015.4 Batsis, 2018, Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies, Nat. Rev. Endocrinol., 14, 513, 10.1038/s41574-018-0062-9 Battson, 2018, The gut microbiota as a novel regulator of cardiovascular function and disease, J. Nutr. Biochem., 56, 1, 10.1016/j.jnutbio.2017.12.010 Baxter, 2019, Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers, Mbio, 10, e02566, 10.1128/mBio.02566-18 Bellumkonda, 2017, Pathophysiology of heart failure and frailty: a common inflammatory origin?, Aging Cell, 16, 444, 10.1111/acel.12581 Beltrami, 2019, Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: an unresolved problem, Monaldi Arch. Chest Dis., 89, 10.4081/monaldi.2019.1026 Benjamin, 2019, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association, Circulation, 139, e56, 10.1161/CIR.0000000000000659 Bennett, 2016, Lipid mediators in inflammation, Microbiol. Spectr., 4, 10.1128/microbiolspec.MCHD-0035-2016 Berg, 2019, Epicardial adipose tissue in cardiovascular disease, Adv. Exp. Med. Biol., 1127, 131, 10.1007/978-3-030-11488-6_9 Bernard, 2018, Double-negative B cells, Nat. Rev. Rheumatol., 14, 684, 10.1038/s41584-018-0113-6 Bhaskaran, 2018, Role of short chain fatty acids in controlling tregs and immunopathology during mucosal infection, Front. Microbiol., 9, 1995, 10.3389/fmicb.2018.01995 Biagi, 2010, Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians, PLoS One, 5, e10667, 10.1371/journal.pone.0010667 Biran, 2017, Quantitative identification of senescent cells in aging and disease, Aging Cell, 16, 661, 10.1111/acel.12592 Bodine, 2014, Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1, Am. J. Physiol. Endocrinol. Metab., 307, E469, 10.1152/ajpendo.00204.2014 Bohnert, 2016, Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia, FASEB J., 30, 3053, 10.1096/fj.201600250RR Borlaug, 2014, The pathophysiology of heart failure with preserved ejection fraction, Nat. Rev. Cardiol., 11, 507, 10.1038/nrcardio.2014.83 Bozkurt, 2018, What is new in heart failure management in 2017? Update on ACC/AHA heart failure guidelines, Curr. Cardiol. Rep., 20, 39, 10.1007/s11886-018-0978-7 Bragoszewski, 2017, Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system, Open Biol., 4, 170007, 10.1098/rsob.170007 Branca, 2019, Intestinal epithelial barrier functions in ageing, Ageing Res. Rev., 54, 100938, 10.1016/j.arr.2019.100938 Brault, 2010, Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy, J. Biol. Chem., 285, 19460, 10.1074/jbc.M110.113092 Bravo-San Pedro, 2017, Autophagy and mitophagy in cardiovascular disease, Circ. Res., 120, 1812, 10.1161/CIRCRESAHA.117.311082 Breitbart, 2011, Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting, Am. J. Physiol. Heart Circ. Physiol., 300, 10.1152/ajpheart.00200.2011 Brown, 2018, Microbial modulation of cardiovascular disease, Nat. Rev. Microbiol., 16, 171, 10.1038/nrmicro.2017.149 Brunt, 2019, Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice, J. Physiol., 597, 2361, 10.1113/JP277336 Buigues, 2016, Effect of a prebiotic formulation on frailty syndrome: a randomized, Double-Blind Clinical Trial. Int. J. Mol. Sci, 17, E932 Burton, 2018, Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing, Biogerontology, 19, 447, 10.1007/s10522-018-9763-7 Caër, 2017, Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue, Sci. Rep., 7, 3000, 10.1038/s41598-017-02660-w Caland, 2019, Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice, Aging (Albany NY), 11, 3832, 10.18632/aging.102020 Campisi, 2011, Cellular senescence: putting the paradoxes in perspective, Curr. Opin. Genet. Dev., 21, 107, 10.1016/j.gde.2010.10.005 Campisi, 2019, From discoveries in ageing research to therapeutics for healthy ageing, Nature, 571, 183, 10.1038/s41586-019-1365-2 Cani, 2009, Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota, Curr. Opin. Pharmacol., 9, 737, 10.1016/j.coph.2009.06.016 Carbone, 2019, Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia, Curr. Probl. Cardiol., 10.1016/j.cpcardiol.2019.03.006 Casati, 2019, Gut microbiota and physical frailty through the mediation of sarcopenia, Exp. Gerontol., 124, 10.1016/j.exger.2019.110639 Castoldi, 2016, The macrophage switch in obesity development, Front. Immunol., 6, 637, 10.3389/fimmu.2015.00637 Chang, 2019, Increased dynamin-related protein 1-dependent mitochondrial fission contributes to high-fat-diet-induced cardiac dysfunction and insulin resistance by elevating tafazzin in mouse hearts, Mol. Nutr. Food Res., 63, 10.1002/mnfr.201801322 Chen, 2019, Increased circulating trimethylamine N-oxide plays a contributory role in the development of endothelial dysfunction and hypertension in the RUPP rat model of preeclampsia, Hypertens. Pregnancy, 38, 96, 10.1080/10641955.2019.1584630 Chen, 2017, Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway, J. Am. Heart Assoc., 6, 10.1161/JAHA.117.006347 Chen, 2019, Predictive value of serum myostatin for the severity and clinical outcome of heart failure, Eur. J. Intern. Med., 64, 33, 10.1016/j.ejim.2019.04.017 Chen, 2016, Lactobacillus plantarum TWK10 supplementation improves exercise performance and increases muscle mass in mice, Nutrients, 8, 205, 10.3390/nu8040205 Cherpokova, 2019, Resolvin D4 attenuates the severity of pathological thrombosis in mice, Blood Chiang, 2017, Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors, Mol. Aspects Med., 58, 114, 10.1016/j.mam.2017.03.005 Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 Cholesterol Treatment Trialists’ Collaboration, 2019, Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials, Lancet, 393, 407, 10.1016/S0140-6736(18)31942-1 Chung, 2019, Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept, Aging Dis., 10, 367, 10.14336/AD.2018.0324 Claesson, 2012, Gut microbiota composition correlates with diet and health in the elderly, Nature, 488, 78, 10.1038/nature11319 Cleland, 2019, The year in cardiology 2018: heart failure, Eur. Heart J., 40, 651, 10.1093/eurheartj/ehz010 Clements, 2018, Diet, the intestinal microbiota, and immune health in aging, Crit. Rev. Food Sci. Nutr., 58, 651, 10.1080/10408398.2016.1211086 Coen, 2019, Mitochondria as a target for mitigating sarcopenia, Front. Physiol., 9, 1883, 10.3389/fphys.2018.01883 Collamati, 2016, Sarcopenia in heart failure: mechanisms and therapeutic strategies, J. Geriatr. Cardiol., 13, 615 Collins, 2018, Obesity, metabolic syndrome, and musculoskeletal disease: common inflammatory pathways suggest a central role for loss of muscle integrity, Front. Physiol., 9, 112, 10.3389/fphys.2018.00112 Conte, 2019, The dual role of the pervasive "Fattish" tissue remodeling with age, Front. Endocrinol. (Lausanne), 10, 114, 10.3389/fendo.2019.00114 Conte, 2018, Pro-resolving lipid mediators in vascular disease, J. Clin. Invest., 128, 3727, 10.1172/JCI97947 Costamagna, 2015, Role of inflammation in muscle homeostasis and myogenesis, Mediators Inflamm., 2015, 10.1155/2015/805172 Cruz-Jentoft, 2019, Sarcopenia: revised European consensus on definition and diagnosis, Age Ageing, 10.1093/ageing/afz046 Cui, 2018, Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients, Sci. Rep., 8, 635, 10.1038/s41598-017-18756-2 da Silva, 2019, The bystander effect contributes to the accumulation of senescent cells in vivo, Aging Cell, 18, 12848, 10.1111/acel.12848 Davalos, 2010, Senescent cells as a source of inflammatory factors for tumor progression, Cancer Metastasis Rev., 29, 273, 10.1007/s10555-010-9220-9 Davis, 2019, Inflammatory diet and preclinical cardiovascular phenotypes in 11–12 year-olds and mid-life adults: a cross-sectional population-based study, Atherosclerosis, 285, 93, 10.1016/j.atherosclerosis.2019.04.212 De Angelis, 2019, Cross talk between neurohormonal pathways and the immune system in heart failure: a review of the literature, Int. J. Mol. Sci., 20, E1698, 10.3390/ijms20071698 Desai, 2018, Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases, Exp. Biol. Med. (Maywood), 243, 554, 10.1177/1535370217752351 de Sire, 2018, Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases, Minerva Gastroenterol. Dietol., 64, 351, 10.23736/S1121-421X.18.02511-4 DeFuria, 2013, B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile, Proc. Natl. Acad. Sci. U. S. A., 110, 5133, 10.1073/pnas.1215840110 Dhillon, 2017, Pathogenesis and management of Sarcopenia, Clin. Geriatr. Med., 33, 17, 10.1016/j.cger.2016.08.002 Diamantis, 2017, The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature, Curr. Cardiol. Rev., 13, 209, 10.2174/1573403X13666170426104611 Dick, 2016, Chronic heart failure and inflammation: what do we really know?, Circulation, 119, 159, 10.1161/CIRCRESAHA.116.308030 Ding, 2016, Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice, Hepatology, 64, 760, 10.1002/hep.28689 Dona, 2008, Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets, Blood, 112, 848, 10.1182/blood-2007-11-122598 Dong, 2016, Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues, Int. J. Obes. (Lond.), 40, 434, 10.1038/ijo.2015.200 Doyle, 2018, Pro-resolving lipid mediators: agents of anti-ageing?, Semin. Immunol., 40, 36, 10.1016/j.smim.2018.09.002 D’Souza, 2016, Lipid metabolism and signaling in cardiac lipotoxicity, Biochim. Biophys. Acta, 1861, 1513, 10.1016/j.bbalip.2016.02.016 Duan, 2019, Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets, FASEB J., 10.1096/fj.201900665RR Duca, 2014, Metabolic interplay between gut bacteria and their host, Front. Horm. Res., 42, 73, 10.1159/000358315 Duchesne, 2017, Impact of inflammation and anti-inflammatory modalities on skeletal muscle healing: from fundamental research to the clinic, Phys. Ther., 97, 807, 10.1093/ptj/pzx056 Duffney, 2018, Key roles for lipid mediators in the adaptive immune response, J. Clin. Invest., 128, 2724, 10.1172/JCI97951 Dunlay, 2017, Epidemiology of heart failure with preserved ejection fraction, Nat. Rev. Cardiol., 14, 591, 10.1038/nrcardio.2017.65 Ebel, 2014, Impact of probiotics on risk factors for cardiovascular diseases. A review, Crit. Rev. Food Sci. Nutr., 54, 175, 10.1080/10408398.2011.579361 Elliott, 2017, Efferocytosis signaling in the regulation of macrophage inflammatory responses, J. Immunol., 198, 1387, 10.4049/jimmunol.1601520 Elnabawi, 2019, Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study, Cardiovasc. Res., 115, 721, 10.1093/cvr/cvz009 Emami, 2018, Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating Heart Failure (SICA-HF), Eur. J. Heart Fail., 20, 1580, 10.1002/ejhf.1304 Exley, 2014, Interplay between the immune system and adipose tissue in obesity, J. Endocrinol., 223, R41, 10.1530/JOE-13-0516 Ferrara, 2019, Impact of different ectopic fat depots on cardiovascular and metabolic diseases, J. Cell. Physiol., 10.1002/jcp.28821 Ferrucci, 2018, Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty, Nat. Rev. Cardiol., 15, 505, 10.1038/s41569-018-0064-2 Ferrucci, 2018, Time and the metrics of aging, Circ. Res., 123, 740, 10.1161/CIRCRESAHA.118.312816 Ferrucci, 2002, Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels, J. Am. Geriatr. Soc., 50, 1947, 10.1046/j.1532-5415.2002.50605.x Filippi, 2017, Dynamin-related protein 1-dependent mitochondrial fission changes in the dorsal vagal complex regulate insulin action, Cell Rep., 18, 2301, 10.1016/j.celrep.2017.02.035 Filippin, 2015, Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention, Aging Clin. Exp. Res., 27, 249, 10.1007/s40520-014-0281-4 Finucane, 2014, A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter, PLoS One, 9, 10.1371/journal.pone.0084689 Fogarty, 2019, Impact of sarcopenia on diaphragm muscle fatigue, Exp. Physiol., 10.1113/EP087558 Forkosh, 2019, The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy, Open Heart, 6, 10.1136/openhrt-2018-000993 Fouré, 2017, Is branched-chain amino acids supplementation an efficient nutritional strategy to alleviate skeletal muscle damage? A systematic review, Nutrients, 9, 1047, 10.3390/nu9101047 Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann. N. Y. Acad. Sci., 908, 244, 10.1111/j.1749-6632.2000.tb06651.x Franceschi, 2018, Inflammaging: a new immune-metabolic viewpoint for age-related diseases, Nat. Rev. Endocrinol., 14, 576, 10.1038/s41574-018-0059-4 Franceschi, 2017, Inflammaging and 'garb-aging', Trends Endocrinol. Metab., 28, 199, 10.1016/j.tem.2016.09.005 Fransen, 2017, Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice, Front. Immunol., 8, 1385, 10.3389/fimmu.2017.01385 Frasca, 2017, Adipose tissue inflammation induces B cell inflammation and decreases B cell function in aging, Front. Immunol., 8, 1003, 10.3389/fimmu.2017.01003 Frasca, 2017, Aging, obesity, and inflammatory age-related diseases, Front. Immunol., 8, 1745, 10.3389/fimmu.2017.01745 Fredman, 2019, Can inflammation-resolution provide clues to treat patients according to their plaque phenotype?, Front. Pharmacol., 10, 205, 10.3389/fphar.2019.00205 Fredman, 2017, Specialized pro-resolving mediators in cardiovascular diseases, Mol. Asp. Med., 58, 65, 10.1016/j.mam.2017.02.003 Frost, 2002, Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle, Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, R698, 10.1152/ajpregu.00039.2002 Fullerton, 2016, Resolution of inflammation: a new therapeutic frontier, Nat. Rev. Drug Discov., 15, 551, 10.1038/nrd.2016.39 Fulop, 2018, Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?, Front. Immunol., 8, 1960, 10.3389/fimmu.2017.01960 Fulop, 2015, Frailty, inflammation and immunosenescence, Interdiscip. Top. Gerontol. Geriatr., 41, 26, 10.1159/000381134 Fülster, 2013, Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)), Eur. Heart J., 34, 512, 10.1093/eurheartj/ehs381 Gaborit, 2017, Role of epicardial adipose tissue in health and disease: a matter of fat?, Compr. Physiol., 7, 1051, 10.1002/cphy.c160034 Ganesh, 2018, Prebiotics, probiotics, and acetate supplementation prevent hypertension in a model of obstructive sleep apnea, Hypertension, 72, 1141, 10.1161/HYPERTENSIONAHA.118.11695 García-Hernández, 2018, Frequency of regulatory B cells in adipose tissue and peripheral blood from individuals with overweight, obesity and normal-weight, Obes. Res. Clin. Pract., 12, 513, 10.1016/j.orcp.2018.07.001 GBD 2015 Obesity Collaborators, 2017, Health effects of overweight and obesity in 195 countries over 25 years, N. Engl. J. Med., 377, 13, 10.1056/NEJMoa1614362 Gérard, 2017, Gut microbiome and obesity. How to prove causality?, Ann. Am. Thorac. Soc., 14, S354, 10.1513/AnnalsATS.201702-117AW Ghosh, 2015, Elevated muscle TLR4 expression and metabolic endotoxemia in human aging, J. Gerontol. A Biol. Sci. Med. Sci., 70, 232, 10.1093/gerona/glu067 Giannakis, 2019, Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration, Nat. Immunol., 20, 626, 10.1038/s41590-019-0356-7 Gill, 2001, Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019, Am. J. Clin. Nutr., 74, 833, 10.1093/ajcn/74.6.833 Glaros, 2013, Causes and consequences of low grade endotoxemia and inflammatory diseases, Front. Biosci. (Schol Ed), 5, 754, 10.2741/S405 Goisser, 2015, Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons-a narrative review, Clin. Interv. Aging, 10, 1267 Gonzalez-Freire, 2018, Searching for a mitochondrial root to the decline in muscle function with ageing, J. Cachexia Sarcopenia Muscle, 9, 435, 10.1002/jcsm.12313 Gonzalez-Freire, 2014, The neuromuscular junction: aging at the crossroad between nerves and muscle, Front. Aging Neurosci., 6, 208, 10.3389/fnagi.2014.00208 Gouspillou, 2013, Role of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in denervation-induced atrophy in aged muscle: facts and hypotheses, Longev. Healthspan, 2, 13, 10.1186/2046-2395-2-13 Graham, 2015, Obesity and the gastrointestinal microbiota: a review of associations and mechanisms, Nutr. Rev., 73, 376, 10.1093/nutrit/nuv004 Grant, 2015, Adipose tissue as an immunological organ, Obesity (Silver Spring), 23, 512, 10.1002/oby.21003 Greising, 2018, Diaphragm plasticity in aging and disease: therapies for muscle weakness go from strength to strength, J. Appl. Physiol., 125, 243, 10.1152/japplphysiol.01059.2017 Greulich, 2012, Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction, Circulation, 126, 2324, 10.1161/CIRCULATIONAHA.111.039586 Grosicki, 2018, Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle Axis, Calcif. Tissue Int., 102, 433, 10.1007/s00223-017-0345-5 Grosso, 2014, Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome, Diabetol. Metab. Syndr., 6, 47, 10.1186/1758-5996-6-47 Gurung, 2015, Mitochondria: diversity in the regulation of the NLRP3 inflammasome, Trends Mol. Med., 21, 193, 10.1016/j.molmed.2014.11.008 Guzik, 2017, The role of infiltrating immune cells in dysfunctional adipose tissue, Cardiovasc. Res., 113, 1009, 10.1093/cvr/cvx108 Habiballa, 2019, Mitochondria and cellular senescence: implications for musculoskeletal ageing, Free Radic. Biol. Med., 132, 3, 10.1016/j.freeradbiomed.2018.10.417 Hackam, 2003, Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence, JAMA, 290, 932, 10.1001/jama.290.7.932 Hamer, 2017, Sarcopenic obesity, weight loss, and mortality: the English longitudinal study of ageing, Am. J. Clin. Nutr., 106, 125, 10.3945/ajcn.117.152488 Hansen, 2019, The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes, Front. Pharmacol., 9, 1582, 10.3389/fphar.2018.01582 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med., 352, 1685, 10.1056/NEJMra043430 Harikrishnan, 2019, Diet, the gut microbiome and heart failure, Card. Fail. Rev., 5, 119, 10.15420/cfr.2018.39.2 Heianza, 2017, Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies, J. Am. Heart Assoc., 6, 10.1161/JAHA.116.004947 Heineke, 2010, Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure, Circulation, 121, 419, 10.1161/CIRCULATIONAHA.109.882068 Hida, 2018, Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: the Yakumo study, Mod. Rheumatol., 28, 345, 10.1080/14397595.2017.1349058 Holte, 2017, Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction, Heart, 103, 1521, 10.1136/heartjnl-2016-310875 Hood, 2019, Maintenance of skeletal muscle mitochondria in health, exercise, and aging, Annu. Rev. Physiol., 81, 19, 10.1146/annurev-physiol-020518-114310 Hori, 2013, Is tumor necrosis factor-α friend or foe for chronic heart failure?, Circ. Res., 113, 492, 10.1161/CIRCRESAHA.113.302024 Huang, 2019, Nrf2 deficiency exacerbates frailty and sarcopenia by impairing skeletal muscle mitochondrial biogenesis and dynamics in an age-dependent manner, Exp. Gerontol., 119, 61, 10.1016/j.exger.2019.01.022 Hubackova, 2012, IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine’ bystander senescence’, Aging (Albany NY), 4, 932, 10.18632/aging.100520 Iacobellis, 2016, Epicardial fat: a new cardiovascular therapeutic target, Curr. Opin. Pharmacol., 27, 13, 10.1016/j.coph.2016.01.004 Iacobellis, 2019, Epicardial adipose tissue feeding and overfeeding the heart, Nutrition, 59, 1, 10.1016/j.nut.2018.07.002 Ibebunjo, 2013, Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia, Mol. Cell. Biol., 33, 194, 10.1128/MCB.01036-12 Ishida, 2017, Myostatin signaling is up-regulated in female patients with advanced heart failure, Int. J. Cardiol., 238, 37, 10.1016/j.ijcard.2017.03.153 Jama, 2019, The gut microbiota and blood pressure in experimental models, Curr. Opin. Nephrol. Hypertens., 28, 97, 10.1097/MNH.0000000000000476 Jama, 2019, The gut microbiota and blood pressure in experimental models, Curr. Opin. Nephrol. Hypertens., 28, 97, 10.1097/MNH.0000000000000476 Jin, 2019, The role of intestinal microbiota in cardiovascular disease, J. Cell. Mol. Med., 23, 2343, 10.1111/jcmm.14195 Juillière, 2018, Heart failure with preserved ejection fraction: a systemic disease linked to multiple comorbidities, targeting new therapeutic options, Arch. Cardiovasc. Dis., 111, 766, 10.1016/j.acvd.2018.04.007 Justice, 2018, Cellular senescence biomarker p16INK4a+ cell burden in thigh adipose is associated with poor physical function in older women, J. Gerontol. A Biol. Sci. Med. Sci., 73, 939, 10.1093/gerona/glx134 Kaeberlein, 2015, Healthy aging: the ultimate preventative medicine, Science, 350, 1191, 10.1126/science.aad3267 Kalinkovich, 2018, Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis, Immunol. Res., 66, 696, 10.1007/s12026-018-9048-x Kalinkovich, 2015, Sarcopenia—the search for emerging biomarkers, Ageing Res. Rev., 22, 58, 10.1016/j.arr.2015.05.001 Kalinkovich, 2017, Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis, Ageing Res. Rev., 35, 200, 10.1016/j.arr.2016.09.008 Karbach, 2016, Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction, J. Am. Heart Assoc., 5, 10.1161/JAHA.116.003698 Kasselman, 2018, The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity, Atherosclerosis, 271, 203, 10.1016/j.atherosclerosis.2018.02.036 Kawamura, 2019, Effects of chronic Porphyromonas gingivalis lipopolysaccharide infusion on skeletal muscles in mice, J. Physiol. Sci., 69, 503, 10.1007/s12576-019-00670-z Keller, 2019, Sarcopenia, Wien. Med. Wochenschr., 169, 157, 10.1007/s10354-018-0618-2 Kelley, 2015, Stewing in not-so-good juices: interactions of skeletal muscle with adipose secretions, Diabetes, 64, 3055, 10.2337/db15-0403 Kelley, 2017, Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology, Heart Fail. Rev., 22, 191, 10.1007/s10741-016-9549-4 Kim, 2015, The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease, J. Cell. Biochem., 116, 1171, 10.1002/jcb.25077 Kiousi, 2019, Probiotics in extraintestinal diseases: current trends and new directions, Nutrients, 11, E788, 10.3390/nu11040788 Kitaoka, 2019, Effects of Nrf2 deficiency on mitochondrial oxidative stress in aged skeletal muscle, Physiol. Rep., 7, 10.14814/phy2.13998 Kitessa, 2016, Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates, Nutrients, 8, E466, 10.3390/nu8080466 Kob, 2015, Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?, Biogerontology, 16, 15, 10.1007/s10522-014-9539-7 Koh, 2016, From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041 Korostishevsky, 2016, Genomics and metabolomics of muscular mass in community-based sample of UK females, Eur. J. Hum. Genet., 24, 277, 10.1038/ejhg.2015.85 Krack, 2005, The importance of the gastrointestinal system in the pathogenesis of heart failure, Eur. Heart J., 26, 2368, 10.1093/eurheartj/ehi389 Krause, 2019, Adiponectin-consideration for its role in skeletal muscle health, Int. J. Mol. Sci., 20, 10.3390/ijms20071528 Krizhanovsky, 2008, Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology, Cold Spring Harb. Symp. Quant. Biol., 73, 513, 10.1101/sqb.2008.73.048 Kufer, 2016, Multifaceted functions of NOD-Like receptor proteins in myeloid cells at the intersection of innate and adaptive immunity, Microbiol. Spectr., 4, 4, 10.1128/microbiolspec.MCHD-0021-2015 Kurdi, 2006, Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria, J. Bacteriol., 188, 1979, 10.1128/JB.188.5.1979-1986.2006 Kwon, 2013, Adipokines mediate inflammation and insulin resistance, Front. Endocrinol. (Lausanne), 4, 71, 10.3389/fendo.2013.00071 Lakshminarayanan, 2014, Compositional dynamics of the human intestinal microbiota with aging: implications for health, J. Nutr. Health Aging, 18, 773, 10.1007/s12603-014-0549-6 Lavie, 2018, Ubiquitin-dependent degradation of mitochondrial proteins regulates energy metabolism, Cell Rep., 23, 2852, 10.1016/j.celrep.2018.05.013 Lewis-McDougall, 2019, Aged-senescent cells contribute to impaired heart regeneration, Aging Cell, 18, 12931, 10.1111/acel.12931 Ley, 2005, Obesity alters gut microbial ecology, Proc. Natl. Acad. Sci. U. S. A., 102, 11070, 10.1073/pnas.0504978102 Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a Li, 2017, Gut microbiota dysbiosis contributes to the development of hypertension, Microbiome, 5, 14, 10.1186/s40168-016-0222-x Libby, 2010, Clinical implications of inflammation for cardiovascular primary prevention, Eur. Heart J., 31, 777, 10.1093/eurheartj/ehq022 Libby, 2011, Progress and challenges in translating the biology of atherosclerosis, Nature, 473, 317, 10.1038/nature10146 Lind, 2018, Impact of aging on the strength of cardiovascular risk factors: a longitudinal study over 40 years, J. Am. Heart Assoc., 7, 10.1161/JAHA.117.007061 Liu, 2019, Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond, Front. Immunol. Livnat-Levanon, 2011, Ubiquitin-proteasome system and mitochondria—eciprocity, Biochim. Biophys. Acta, 1809, 80, 10.1016/j.bbagrm.2010.07.005 Livshits, 2016, Contribution of heritability and epigenetic factors to skeletal muscle mass variation in United Kingdom twins, J. Clin. Endocrinol. Metab., 101, 2450, 10.1210/jc.2016-1219 Londhe, 2015, Inflammation induced loss of skeletal muscle, Bone, 80, 131, 10.1016/j.bone.2015.03.015 Luck, 2019, Gut-associated IgA+ immune cells regulate obesity-related insulin resistance, Nat. Commun., 10, 3650, 10.1038/s41467-019-11370-y Ludwig, 2018, Lactobacillus rhamnosus GG-derived soluble mediators modulate adaptive immune cells, Front Immunol., 9, 1546, 10.3389/fimmu.2018.01546 Lycke, 2017, The regulation of gut mucosal IgA B-cell responses: recent developments, Mucosal Immunol., 10, 1361, 10.1038/mi.2017.62 Lynch, 2015, Diet-microbiota-health interactions in older subjects: implications for healthy aging, Interdiscip. Top. Gerontol., 40, 141, 10.1159/000364976 Ma, 2018, The role of gut microbiota in atherosclerosis and hypertension, Front. Pharmacol., 9, 1082, 10.3389/fphar.2018.01082 Madonna, 2019, The epicardial adipose tissue and the coronary arteries: dangerous liaisons, Cardiovasc. Res., 115, 1013, 10.1093/cvr/cvz062 Mancuso, 2016, The role of adipokines in chronic inflammation, Immunotargets Ther., 5, 47, 10.2147/ITT.S73223 Marcos-Pérez, 2018, Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations, Front. Immunol., 9, 1056, 10.3389/fimmu.2018.01056 Markousis-Mavrogenis, 2019, The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study, Eur. J. Heart Fail., 21, 965, 10.1002/ejhf.1482 Marques, 2017, High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice, Circulation, 135, 964, 10.1161/CIRCULATIONAHA.116.024545 Marzetti, 2013, Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials, Int. J. Biochem. Cell Biol., 45, 2288, 10.1016/j.biocel.2013.06.024 Mason, 2014, Skeletal muscle reactive oxygen species: a target of good cop/bad cop for exercise and disease, Redox Rep., 19, 97, 10.1179/1351000213Y.0000000077 Mayhew, 2019, The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses, Age Ageing, 48, 48, 10.1093/ageing/afy106 McAninch, 2015, Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease, Obesity (Silver Spring), 23, 1267, 10.1002/oby.21059 McBride, 2017, The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice, Am. J. Physiol. Endocrinol. Metab., 313, E222, 10.1152/ajpendo.00060.2017 McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member, Nature, 387, 83, 10.1038/387083a0 Meijnikman, 2018, Evaluating causality of gut microbiota in obesity and diabetes in humans, Endocr. Rev., 39, 133, 10.1210/er.2017-00192 Michalska-Kasiczak, 2018, Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview, Arch. Med. Sci., 14, 890, 10.5114/aoms.2018.76279 Mishima, 2019, Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells, J. Clin. Invest., 130, 3702, 10.1172/JCI93820 Miyagi, 2018, Diaphragm muscle dysfunction in patients with heart failure, J. Card. Fail., 24, 209, 10.1016/j.cardfail.2017.12.004 Mohan, 2018, Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation, Biomed. Pharmacother., 108, 1866, 10.1016/j.biopha.2018.10.019 Mokkala, 2017, Gut microbiota aberrations precede diagnosis of gestational diabetes mellitus, Acta Diabetol., 54, 1147, 10.1007/s00592-017-1056-0 Montgomery, 2019, Impact of lipotoxicity on tissue "cross talk" and metabolic regulation, Physiology (Bethesda), 34, 134 Moore, 2019, Regulatory B lymphocytes: development and modulation of the host immune response during disease, Immunotherapy, 11, 691, 10.2217/imt-2018-0185 Morley, 2001, Sarcopenia, J. Lab. Clin. Med., 137, 231, 10.1067/mlc.2001.113504 Murphy, 2014, Transition to sarcopenia and determinants of transitions in older adults: a population-based study, J. Gerontol. A Biol. Sci. Med. Sci., 69, 751, 10.1093/gerona/glt131 Nagatomo, 2015, Intersections between microbiome and heart failure: revisiting the gut hypothesis, J. Card. Fail., 21, 973, 10.1016/j.cardfail.2015.09.017 Nagpal, 2018, Gut microbiome and aging: physiological and mechanistic insights, Nutr. Healthy Aging, 4, 267, 10.3233/NHA-170030 Nakamura, 2019, Cardiomyopathy in obesity, insulin resistance and diabetes, J. Physiol., 10.1113/JP276747 Narumi, 2015, Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure, Eur. J. Intern. Med., 26, 118, 10.1016/j.ejim.2015.01.008 NCD Risk Factor Collaboration (NCD-RisC), 2017, Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults, Lancet., 390, 2627, 10.1016/S0140-6736(17)32129-3 Neeland, 2018, Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management, Circulation, 137, 1391, 10.1161/CIRCULATIONAHA.117.029617 Ng, 2018, Impact of epicardial adipose tissue, left ventricular myocardial fat content, and interstitial fibrosis on myocardial contractile function, Circ. Cardiovasc. Imaging, 11, 10.1161/CIRCIMAGING.117.007372 Nicholson, 2018, The role of adipokines in skeletal muscle inflammation and insulin sensitivity, J. Inflamm. (Lond.), 15, 9, 10.1186/s12950-018-0185-8 Nishida, 2017, Inflammation and metabolic cardiomyopathy, Cardiovasc. Res., 113, 389, 10.1093/cvr/cvx012 Ohkura, 2019, Spred2 regulates high fat diet-induced adipose tissue inflammation, and metabolic abnormalities in mice, Front. Immunol., 10, 17, 10.3389/fimmu.2019.00017 Oka, 2012, Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure, Nature, 485, 251, 10.1038/nature10992 Olesen, 2016, Dysbiosis is not an answer, Nat. Microbiol., 1, 16228, 10.1038/nmicrobiol.2016.228 Ono, 2017, Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α, PLoS One, 12, 10.1371/journal.pone.0182040 Ortega-Loubon, 2019, Obesity and its cardiovascular effects, Diabetes Metab. Res. Rev., 35, 10.1002/dmrr.3135 Packer, 1992, The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure, J. Am. Coll. Cardiol., 20, 248, 10.1016/0735-1097(92)90167-L Packer, 2019, Do drugs that ameliorate epicardial adipose tissue inflammation have concordant benefits on atrial fibrillation and on heart failure with a preserved ejection fraction?, J. Card. Fail., 10.1016/j.cardfail.2019.09.002 Pagnini, 2018, Mucosal adhesion and anti-inflammatory effects of Lactobacillus rhamnosus GG in the human colonic mucosa: a proof-of-concept study, World J. Gastroenterol., 24, 4652, 10.3748/wjg.v24.i41.4652 Palmer, 2019, Targeting senescent cells alleviates obesity-induced metabolic dysfunction, Aging Cell, 18, 12950, 10.1111/acel.12950 Pan, 2018, Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation, Panminerva Med., 60, 86, 10.23736/S0031-0808.18.03452-3 Pansarasa, 2019, Altered immune system in frailty: genetics and diet may influence inflammation, Ageing Res. Rev., 54, 10.1016/j.arr.2019.100935 Parisi, 2019, Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue, Int. J. Cardiol., 274, 326, 10.1016/j.ijcard.2018.06.106 Park, 2010, Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe, J. Cardiovasc. Ultrasound, 18, 121, 10.4250/jcu.2010.18.4.121 Parséus, 2017, Microbiota-induced obesity requires farnesoid X receptor, Gut, 66, 429, 10.1136/gutjnl-2015-310283 Pasini, 2016, Pathogenic gut flora in patients with chronic heart failure, JACC Heart Fail., 4, 220, 10.1016/j.jchf.2015.10.009 Patel, 2017, Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease, Heart Fail. Rev., 22, 889, 10.1007/s10741-017-9644-1 Paulus, 2013, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, J. Am. Coll. Cardiol., 62, 263, 10.1016/j.jacc.2013.02.092 Pavlidis, 2015, Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?, Aliment. Pharmacol. Ther., 42, 802, 10.1111/apt.13333 Peng, 2018, Interaction between gut microbiome and cardiovascular disease, Life Sci., 214, 153, 10.1016/j.lfs.2018.10.063 Pérez, 2016, ‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue, J. Physiol., 594, 3187, 10.1113/JP271691 Pezeshkian, 2013, Epicardial and subcutaneous adipose tissue fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft, Bioimpacts, 3, 83 Picca, 2018, Gut dysbiosis and muscle aging: searching for novel targets against Sarcopenia, Mediators Inflamm., 2018, 10.1155/2018/7026198 Picca, 2018, Circulating mitochondrial DNA at the crossroads of mitochondrial dysfunction and inflammation during aging and muscle wasting disorders, Rejuvenation Res., 21, 350, 10.1089/rej.2017.1989 Pillon, 2017, Innate immune receptors in skeletal muscle metabolism, Exp. Cell Res., 360, 47, 10.1016/j.yexcr.2017.02.035 Prata, 2019, Senescent cell clearance by the immune system: emerging therapeutic opportunities, Semin. Immunol., 101275, 10.1016/j.smim.2019.04.003 Prattichizzo, 2018, Inflammageing and metaflammation: the yin and yang of type 2 diabetes, Ageing Res. Rev., 41, 1, 10.1016/j.arr.2017.10.003 Pussinen, 2019, Association of childhood oral infections with cardiovascular risk factors and subclinical atherosclerosis in adulthood, JAMA Netw. Open, 2, 10.1001/jamanetworkopen.2019.2523 Rabot, 2010, Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism, FASEB J., 24, 4948, 10.1096/fj.10-164921 Reijnders, 2016, Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial, Cell Metab., 24, 63, 10.1016/j.cmet.2016.06.016 Ridaura, 2013, Gut microbiota from twins discordant for obesity modulate metabolism in mice, Science, 341, 1241214, 10.1126/science.1241214 Ridker, 2019, Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis, Circ. Res., 124, 437, 10.1161/CIRCRESAHA.118.313129 Ridker, 2017, Antiinflammatory therapy with canakinumab for atherosclerotic disease, N. Engl. J. Med., 377, 1119, 10.1056/NEJMoa1707914 Rinninella, 2019, What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases, Microorganisms, 7, 10.3390/microorganisms7010014 Rivas, 2016, Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity, Am. J. Physiol. Regul. Integr. Comp. Physiol. Roberts, 2018, Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential, Nat. Med., 24, 1407, 10.1038/s41591-018-0128-1 Rodríguez-Nuevo, 2019, The sensing of mitochondrial DAMPs by non-immune cells, Cell Stress, 3, 195, 10.15698/cst2019.06.190 Rogler, 2014, The heart and the gut, Eur. Heart J., 35, 426, 10.1093/eurheartj/eht271 Romanello, 2016, Mitochondrial quality control and muscle mass maintenance, Front. Physiol., 6, 422, 10.3389/fphys.2015.00422 Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat. Rev. Immunol., 16, 341, 10.1038/nri.2016.42 Roos, 2016, Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice, Aging Cell, 15, 973, 10.1111/acel.12458 Rudolf, 2014, Degeneration of neuromuscular junction in age and dystrophy, Front. Aging Neurosci., 6, 99, 10.3389/fnagi.2014.00099 Sabatine, 2019, PCSK9 inhibitors: clinical evidence and implementation, Nat. Rev. Cardiol., 16, 155, 10.1038/s41569-018-0107-8 Sacks, 2011, Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone, Diabetes Care, 34, 730, 10.2337/dc10-2083 Saitoh, 2017, Sarcopenia, cachexia, and muscle performance in heart failure: review update 2016, Int. J. Cardiol., 238, 5, 10.1016/j.ijcard.2017.03.155 Saitoh, 2016, Muscle wasting in heart failure: the role of nutrition, Wien. Klin. Wochenschr., 128, 455, 10.1007/s00508-016-1100-z Sakuma, 2015, Current understanding of sarcopenia: possible candidates modulating muscle mass, Pflugers Arch., 467, 213, 10.1007/s00424-014-1527-x Sandek, 2009, The gut and intestinal bacteria in chronic heart failure, Curr. Drug Metab., 10, 22, 10.2174/138920009787048374 Sapieha, 2018, Cellular senescence in postmitotic cells: beyond growth arrest, Trends Cell Biol., 28, 595, 10.1016/j.tcb.2018.03.003 Savarese, 2019, Incidence, predictors, and outcome associations of dyskalemia in heart failure with preserved, mid-range, and reduced ejection fraction, JACC Heart Fail., 7, 65, 10.1016/j.jchf.2018.10.003 Sayed, 2019, Lack of NLRP3 inflammasome activation reduces age-dependent sarcopenia and mitochondrial dysfunction, favoring the prophylactic effect of melatonin, J. Gerontol. A Biol. Sci. Med. Sci., 10.1093/gerona/glz079 Schiattarella, 2019, Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases, Trends Cardiovasc. Med., 29, 141, 10.1016/j.tcm.2018.08.003 Schiattarella, 2017, Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis, Eur. Heart J., 38, 2948, 10.1093/eurheartj/ehx342 Scott, 2017, Revisiting Metchnikoff: age-related alterations in microbiota-gut-brain axis in the mouse, Brain Behav. Immun., 65, 20, 10.1016/j.bbi.2017.02.004 Sente, 2016, Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure, J. Cachexia Sarcopenia Muscle, 7, 261, 10.1002/jcsm.12086 Sergi, 2019, Mitochondrial (Dys)function and Insulin resistance: from pathophysiological molecular mechanisms to the impact of diet, Front. Physiol., 10, 532, 10.3389/fphys.2019.00532 Serhan, 2017, Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms, FASEB J., 31, 1273, 10.1096/fj.201601222R Serhan, 2015, The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution, Semin. Immunol., 27, 200, 10.1016/j.smim.2015.03.004 Seta, 1996, Basic mechanisms in heart failure: the cytokine hypothesis, J. Card. Fail., 2, 243, 10.1016/S1071-9164(96)80047-9 Shafiee, 2018, Identification of candidate genes and proteins in aging skeletal muscle (sarcopenia) using gene expression and structural analysis, PeerJ, 6, e5239, 10.7717/peerj.5239 Shah, 2019, Inflammation in atherosclerotic cardiovascular disease, F1000Res, 8, 10.12688/f1000research.18901.1 Shimizu, 2019, Cellular senescence in cardiac diseases, J. Cardiol., 10.1016/j.jjcc.2019.05.002 Shin, 2018, Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip, Proc. Natl. Acad. Sci. U. S. A., 115, E10539, 10.1073/pnas.1810819115 Shinmura, 2016, Cardiac senescence, heart failure, and frailty: a triangle in elderly people, Keio J. Med., 65, 25, 10.2302/kjm.2015-0015-IR Shirakawa, 2016, Obesity accelerates T cell senescence in murine visceral adipose tissue, J. Clin. Invest., 126, 4626, 10.1172/JCI88606 Shulman, 2014, Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease, N. Engl. J. Med., 371, 1131, 10.1056/NEJMra1011035 Sima, 2018, Function of pro-resolving lipid mediator resolvin E1 in type 2 diabetes, Crit. Rev. Immunol., 38, 343, 10.1615/CritRevImmunol.2018026750 Soysal, 2016, Inflammation and frailty in the elderly: a systematic review and meta-analysis, Ageing Res. Rev., 31, 1, 10.1016/j.arr.2016.08.006 Springer, 2017, Muscle wasting and sarcopenia in heart failure and beyond: update, ESC Heart Fail., 4, 492, 10.1002/ehf2.12237 Steinbeck, 2015, Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the studies investigating Co-morbidities aggravating heart failure (SICA-H), Eur. J. Heart Fail., 17, 1283, 10.1002/ejhf.400 Stephens, 2018, Gut microbiota: from microorganisms to metabolic organ influencing obesity, Obesity (Silver Spring), 26, 801, 10.1002/oby.22179 Suffee, 2017, Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria, Proc. Natl. Acad. Sci. U. S. A., 114, E771, 10.1073/pnas.1610968114 Sundara Rajan, 2016, Dendritic cells and adipose tissue, Immunology, 149, 353, 10.1111/imm.12653 Suzuki, 2018, Skeletal muscle wasting in chronic heart failure, ESC Heart Fail., 5, 1099, 10.1002/ehf2.12387 Sze, 2016, Looking for a signal in the noise: revisiting obesity and the microbiome, MBio, 7, 10.1128/mBio.01018-16 Szulc, 2016, High risk of fall, poor physical function, and low grip strength in men with fracture-the STRAMBO study, J. Cachexia Sarcopenia Muscle, 7, 299, 10.1002/jcsm.12066 Tanaka, 2014, Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction, Circ. Heart Fail., 7, 976, 10.1161/CIRCHEARTFAILURE.114.001279 Tanase, 2019, Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker?, Int. J. Hypertens., 2019, 10.1155/2019/3159283 Tang, 2014, Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis, J. Am. Coll. Cardiol., 64, 1908, 10.1016/j.jacc.2014.02.617 Tang, 2019, Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review, J. Am. Coll. Cardiol., 73, 2089, 10.1016/j.jacc.2019.03.024 Taylor, 2019, Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study, BMJ, 364, l223, 10.1136/bmj.l223 Theou, 2019, Can a prebiotic formulation reduce frailty levels in older people?, J. Frailty Aging, 8, 48 Thevaranjan, 2017, Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction, Cell Host Microbe, 21, 455, 10.1016/j.chom.2017.03.002 Ticinesi, 2019, The intestinal microbiome and its relevance for functionality in older persons, Curr. Opin. Clin. Nutr. Metab. Care, 22, 4, 10.1097/MCO.0000000000000521 Ticinesi, 2017, Aging gut microbiota at the cross-road between nutrition, physical frailty, and Sarcopenia: is there a gut-muscle Axis?, Nutrients, 9, 10.3390/nu9121303 Tiratterra, 2018, Role of bile acids in inflammatory bowel disease, Ann. Gastroenterol., 31, 266 Toral, 2019, Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats, Acta Physiol. (Oxf.), 10.1111/apha.13285 Trim, 2018, Parallels in immunometabolic adipose tissue dysfunction with ageing and obesity, Front. Immunol., 9, 169, 10.3389/fimmu.2018.00169 Tromp, 2018, Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction, J. Am. Coll. Cardiol., 72, 1081, 10.1016/j.jacc.2018.06.050 Trouwborst, 2018, Ectopic fat accumulation in distinct insulin resistant phenotypes; targets for personalized nutritional interventions, Front. Nutr., 5, 77, 10.3389/fnut.2018.00077 Tsao, 2018, Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction, JACC Heart Fail., 6, 678, 10.1016/j.jchf.2018.03.006 Tseng, 2019, The gut microbiome in obesity, J. Formos. Med. Assoc., 118, S3, 10.1016/j.jfma.2018.07.009 Tsushima, 2018, Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission, Circ. Res., 122, 58, 10.1161/CIRCRESAHA.117.311307 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Tyrovolas, 2016, Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study, J. Cachexia Sarcopenia Muscle, 7, 312, 10.1002/jcsm.12076 Ullrich, 2019, SPRED2 deficiency elicits cardiac arrhythmias and premature death via impaired autophagy, J. Mol. Cell. Cardiol., 129, 13, 10.1016/j.yjmcc.2019.01.023 Vaiserman, 2017, Gut microbiota: a player in aging and a target for anti-aging intervention, Ageing Res. Rev., 35, 36, 10.1016/j.arr.2017.01.001 van den Munckhof, 2018, Rutten JHW1. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies, Obes. Rev., 19, 1719, 10.1111/obr.12750 van der Heijden, 2017, NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report, Arterioscler. Thromb. Vasc. Biol., 37, 1457, 10.1161/ATVBAHA.117.309575 van Hout, 2017, The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction, Eur. Heart J., 38, 828 Van Linthout, 2017, Inflammation—cause or consequence of heart failure or both? Curr, Heart Fail. Rep., 14, 251, 10.1007/s11897-017-0337-9 Vanitallie, 2003, Frailty in the elderly: contributions of sarcopenia and visceral protein depletion, Metabolism, 52, 22, 10.1016/S0026-0495(03)00297-X Vasavan, 2018, Heart and bile acids—clinical consequences of altered bile acid metabolism, Biochim Biophys. Acta Mol. Basis Dis., 1864, 1345, 10.1016/j.bbadis.2017.12.039 Vasilaki, 2017, Role of nerve-muscle interactions and reactive oxygen species in regulation of muscle proteostasis with ageing, J. Physiol., 595, 6409, 10.1113/JP274336 Vella, 2019, Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men, Physiol. Rep., 7, 10.14814/phy2.14108 Ventura, 2017, Immunosenescence in aging: between immune cells depletion and cytokines up-regulation, Clin. Mol. Allergy, 15, 21, 10.1186/s12948-017-0077-0 von Haehling, 2017, Muscle wasting and cachexia in heart failure: mechanisms and therapies, Nat. Rev. Cardiol., 14, 323, 10.1038/nrcardio.2017.51 von Haehling, 2010, An overview of sarcopenia: facts and numbers on prevalence and clinical impact, J. Cachexia Sarcopenia Muscle, 1, 129, 10.1007/s13539-010-0014-2 Vonderlin, 2019, Critical inflammatory mechanisms underlying arrhythmias, Herz, 44, 121, 10.1007/s00059-019-4788-5 Walters, 2014, Meta-analyses of human gut microbes associated with obesity and IBD, FEBS Lett., 588, 4223, 10.1016/j.febslet.2014.09.039 Wang, 2017, Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses, Mol. Aspects Med., 58, 93, 10.1016/j.mam.2017.02.002 Wen, 2011, Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling, Nat. Immunol., 12, 408, 10.1038/ni.2022 Wensveen, 2015, The Big Bang in obese fat: events initiating obesity-induced adipose tissue inflammation, Eur. J. Immunol., 45, 2446, 10.1002/eji.201545502 Westermann, 2011, Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction, Circ. Heart Fail., 4, 44, 10.1161/CIRCHEARTFAILURE.109.931451 Wilson, 2017, Frailty and sarcopenia: the potential role of an aged immune system, Ageing Res. Rev., 36, 1, 10.1016/j.arr.2017.01.006 Winer, 2014, B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance, Cell. Mol. Life Sci., 71, 1033, 10.1007/s00018-013-1486-y Wong, 2019, Interpreting the findings from the recent PCSK9 monoclonal antibody cardiovascular outcomes trials, Front. Cardiovasc. Med., 6, 14, 10.3389/fcvm.2019.00014 Wu, 2017, Skeletal muscle inflammation and insulin resistance in obesity, J. Clin. Invest., 127, 43, 10.1172/JCI88880 Wu, 2015, Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine, Biomedicine (Taipei), 5, 1, 10.7603/s40681-015-0001-1 Wu, 2011, The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex, Cell Metab., 13, 160, 10.1016/j.cmet.2011.01.003 Xu, 2018, Senolytics improve physical function and increase lifespan in old age, Nat. Med., 24, 1246, 10.1038/s41591-018-0092-9 Xue, 2019, The chemokine system and its role in obesity, J. Cell. Physiol., 234, 3336, 10.1002/jcp.27293 Yamada, 2015, Frailty may be a risk marker for adverse outcome in patients with congestive heart failure, ESC Heart Fail., 2, 168, 10.1002/ehf2.12052 Yanes, 2017, Lymphocyte generation and population homeostasis throughout life, Semin. Hematol., 54, 33, 10.1053/j.seminhematol.2016.10.003 Yao, 2018, Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation, Circulation, 138, 2227, 10.1161/CIRCULATIONAHA.118.035202 Yu, 2016, The role of mitochondrial DNA damage in the development of atherosclerosis, Free Radic. Biol. Med., 100, 223, 10.1016/j.freeradbiomed.2016.06.011 Yu, 2016, Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance, Arch. Pharm. Res., 39, 1503, 10.1007/s12272-016-0827-4 Yudkin, 2005, "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, Lancet, 365, 1817, 10.1016/S0140-6736(05)66585-3 Yurdagul, 2018, Mechanisms and consequences of defective efferocytosis in atherosclerosis, Front. Cardiovasc. Med., 4, 86, 10.3389/fcvm.2017.00086 Zamboni, 2019, Sarcopenia and obesity, Curr. Opin. Clin. Nutr. Metab. Care, 22, 13, 10.1097/MCO.0000000000000519 Zhan, 2017, Reduced inflammatory responses of follicular helper T cell promote the development of regulatory B cells after Roux-en-Y gastric bypass, Clin. Exp. Pharmacol. Physiol., 44, 556, 10.1111/1440-1681.12740 Zhang, 2019, Fermented dairy foods intake and risk of cardiovascular diseases: a meta-analysis of cohort studies, Crit. Rev. Food Sci. Nutr., 1 Zhang, 2017, Immune mechanisms in heart failure, Eur. J. Heart Fail., 19, 1379, 10.1002/ejhf.942 Zhao, 2013, The gut microbiota and obesity: from correlation to causality, Nat. Rev. Microbiol., 11, 639, 10.1038/nrmicro3089